Leitlinienprogramm OnkologieCervical Carcinoma

27. Anhang – Cervical Carcinoma

Version 2.2 · March 2022 · AWMF 032/033OL
Leitlinienprogramm Onkologie · Deutsche Krebsgesellschaft · Deutsche Krebshilfe · AWMF

Table 15: Übersicht der TNM-Kategorien/ FIGO-Stadien (modifiziert 2021)

TNM categories

FIGO-
Stages
(2009)

Definition

FIGO Stages (2018)

Definition

TX

-

Primary tumor cannot be assessed

 

-

0

-

No evidence of primary tumor

 

-

Tis

- ¹

Carcinoma in situ (preinvasive carcinoma; adenocarcinoma in situ, stratified mucin-producing lesion; SIMLE)

- ¹

-

1

I

Tumor confined to the cervix

I

Tumor confined to the cervix

T1a

IA

Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm, with a horizontal spread of 7.0 mm or less

IA

Invasive carcinoma diagnosed only by microscopy. Stromal invasion to a maximum depth of 5.0 mm ²

T1a1

IA1

Stromal invasion of ≤ 3.0 mm in depth and ≤ 7.0 mm in horizontal spread

IA1

Stromal invasion of ≤ 3.0 mm in depth²

T1a2

IA2

Stromal invasion of > 3.0 mm and ≤ 5.0 mm with a horizontal spread of 7.0 mm or less

IA2

Stromal invasion of more than 3.0 mm but no more ≤ 5.0 mm ²

 

IB

(Macroscopically) visible lesion, confined to the cervix, or microscopic lesion > T1a2 / IA2

IB

Clinically (macroscopically) visible lesion, confined to the cervix, or microscopic lesion > T1a2 / IA2

T1b1

IB1

Clinically (macroscopically) visible lesion, ≤ 4.0 cm in largest extent

IB1

Clinically (macroscopically) visible lesion, ≤ 2.0 cm in largest extent

T1b2

IB2

Clinically (macroscopically) visible lesion, > 4.0 cm in largest extent

IB2

Clinically (macroscopically) visible lesion, > 2.0 cm but ≤ 4.0cm in largest extent

Tb3

-

-

IB3

(Macroscopically) visible lesion, more than 4.0 cm in largest extent

 

II

Tumor invading beyond the uterus, but not as far as the pelvic wall and not to the lower third of the vagina

II

Tumor invading beyond the uterus, but not as far as the pelvic wall and not to the lower third of the vagina

T2a

IIA

Tumor with spread into the vagina (proximal and/or middle third), but without invasion of the parametrium

IIA

Tumor with spread into the vagina (proximal and/or middle third), but without invasion of the parametrium

T2a1

IIA1

Clinically (macroscopically) visible lesion ≤ 4.0 cm at largest extent

IIA1

Clinically (macroscopically) visible lesion ≤ 4.0 cm at largest extent

T2a2

IIA2

Clinically (macroscopically) visible lesion > 4.0 cm at largest extent

IIA2

Clinically (macroscopically) visible lesion > 4.0 cm at largest extent

T2b

IIB

Tumor with invasion of the parametrium, but not as far as the pelvic wall

IIB

Tumor with invasion of the parametrium, but not as far as the pelvic wall

T3

III

Tumor extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or nonfunctional kidney

III

Tumor extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or nonfunctional kidney

T3a

IIIA

Tumor involves the lower third of the vagina, with no extension to the pelvic wall

IIIA

Tumor involves the lower third of the vagina, with no extension to the pelvic wall

T3b

IIIB

Tumor extends to the pelvic wall and/or causes hydronephrosis or nonfunctional kidney

IIIB

Tumor extends to the pelvic wall and/or causes hydronephrosis or nonfunctional kidney

pN1 or pM1

IVa

Metastases in the pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent

IIIC

Metastases in the pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent

pN1

IVa

Metastases only in pelvic lymph nodes

IIIC1

Metastases only in pelvic lymph nodes⁴

pM1

IVa

Metastases in para-aortic lymph nodes (independently of whether or not pelvic lymph nodes are involved)

IIIC2

Metastases in para-aortic lymph nodes (independently of whether or not pelvic lymph nodes are involved)⁴

T4

IV

Tumor invades the mucosa of the bladder or rectum or extends beyond the boundary of the lesser pelvis

IV

Tumor invades the mucosa of the bladder or rectum or extends beyond the boundary of the lesser pelvis

T4

IVa

Tumor invades the mucosa of the bladder or rectum or extends beyond the boundary of the lesser pelvis

IVa

Spread into organs of the lesser pelvis

M1

IVb

Distant metastases, including metastases in para-aortic lymph nodes

IVb

Distant metastases

         

 

N classification of regional lymph nodes (pelvic):
NX = regional lymph nodes cannot be assessed
N0 = No regional lymph node metastases
N1 = Regional lymph node metastases

M classification of distant metastases (including para-aortic lymph nodes):
cM0 = No clinical evidence of distant metastases
cM1 = Clinical evidence of distant metastases
pM1 = Histological confirmation of distant metastases
pM0 = Histologically confirmed distant metastases

Lymphatic invasion (L-status):
LX = Invasion of lymphatic vessels cannot be assessed
L0 = No lymphatic invasion
L1 = Evidence of lymphatic invasion

Vascular invasion (V status):
VX = Vascular invasion cannot be assessed
V0 = No vascular invasion
V1 = Evidence of vascular invasion

Invasion of the perineural sheaths (Pn status):
PnX = Perineural invasion cannot be assessed
Pn0 = No perineural invasion
Pn1 = Evidence of perineural invasion

  1. Carcinoma in situ is not included in the respective FIGO classification, but is anchored in the TNM classification.
  2. Horizontal extension is no longer relevant for staging in the 2018 FIGO classification. However, no rationale is given for this by FIGO, nor are any relevant studies cited.
  3. In the 2018 FIGO classification, para-aortic lymph nodes are now defined as regional lymph nodes; this proposal is also followed in the revised reprint of the TNM classification [868].
  4. It was suggested by FIGO in 2019 that adding the notation “r” (imaging) and “p” (pathology) would indicate the method by which the finding was established.

Table 16: Übersicht der UICC-Stadien (geprüft 2021)

UICC stage

Corresponding TNM categories

0

Tis

N0

M0

IA

T1a

N0

M0

IA1

T1a1

N0

M0

IA2

T1a2

N0

M0

IB

T1b

N0

M0

IB1

T1b1

N0

M0

IB2

T1b2

N0

M0

II

T2

N0

M0

IIA

T2a

N0

M0

IIA1

T2a1

N0

M0

IIA2

T2a2

N0

M0

IIB

T2b

N0

M0

III

T3

N0

M0

IIIA

T3a

N0

M0

IIIB

T1, T2, T3a

N1

M0

 

T3B

Any N

M0

IVA

T4

Any N

M0

IVB

Any T

Any N

M1

 

References

[868] Wittekind, C, TNM Klassifikation maligner Tumoren - Korrigierter Nachdruck 2020 mit allen Ergänzungen der UICC aus den Jahren 2017 bis 2019Wiley-VCH, Weinheim, 2020.